Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Development phase – Control participants:
- People who are over 18 years old
- People who are willing to give their agreement to take part in the study
- People who do not have any concerns or complaints about their memory
Clinical phase – Patients:
- People who are 65 years old or older
- People who are able to give their agreement to take part in the study
- People who have been formally diagnosed with Alzheimer's disease by a mental health team
Clinical phase – Control participants:
- People who are 65 years old or older
- People who are able to give their agreement to take part in the study
- People who have scored within the normal range on two standard memory and thinking tests (confirm with trial site for details on these tests)
- People who do not have any concerns or complaints about their memory
Who may not be able to join:
- People with a history of diabetes
- People who have had a major stroke (note: mini-strokes or certain smaller types of stroke may still be acceptable — confirm with trial site)
- People who cannot have an MRI scan, for example due to having an implanted heart device
- People with a family history of Alzheimer's disease, due to possible genetic factors
- People with advanced Alzheimer's disease who are not able to give their own agreement to participate
- People who are pregnant (for the development phase)
- People who are unable to read or speak English
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gordon Waiter, PhD, University of Aberdeen
Phone: +44 (0)1224 438356
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PET glucose measurement; CEST-MRI glucose measurement; Sensitivity and specificity of CEST-MRI glucose measurements; Repeatability of CEST-MRI glucose measurement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.